e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Going with the flow: assessment and evaluation of airway function and its role in patient management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pressure supported nasal inhalation improving penetration of particles into the human lung
K. Sohrabi, D. Librizzi, A. Sohrabi, M. Scholtes, H. Hoeffken, U. Koehler, V. Gross (Giessen, Germany)
Source:
Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Session:
Going with the flow: assessment and evaluation of airway function and its role in patient management
Session type:
Thematic Poster Session
Number:
1139
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Sohrabi, D. Librizzi, A. Sohrabi, M. Scholtes, H. Hoeffken, U. Koehler, V. Gross (Giessen, Germany). Pressure supported nasal inhalation improving penetration of particles into the human lung. Eur Respir J 2012; 40: Suppl. 56, 1139
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Lung deposition of an aerosol produced by a new inhalation device for ventilated patients
Source: Eur Respir J 2005; 26: Suppl. 49, 88s
Year: 2005
Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion
Source: ERJ Open Res, 7 (1) 00519-2020; 10.1183/23120541.00519-2020
Year: 2021
LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Late Breaking Abstract - Exhaled air dispersion during application of CPAP via nasal pillows and oronasal mask versus high flow nasal cannula therapy
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018
Exchange of highly soluble gases in the lung airways with the bronchial circulation
Source: Eur Respir J 2004; 24: Suppl. 48, 327s
Year: 2004
High flow nasal cannula: influence of gas type and flow rate on positive airway pressure and CO2 clearance in adult nasal airway replicas
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019
Coupling of noninvasive mechanical ventilation and nebulization during asthma exacerbations: higher amount of aerosol deposition into the airways or effective mechanical brochodilation due to positive pressure?
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009
Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Exhaled air dispersion and use of oronasal masks with continuous positive airway pressure during COVID-19
Source: Eur Respir Rev, 29 (157) 200144; 10.1183/16000617.0144-2020
Year: 2020
Exhaled air leakage during application of high flow nasal cannula on a human patient simulator
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017
Controlled inhalation improves total and peripheral lung deposition in CF
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Reduced lung function and exhaled lining fluid from small airways
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006
Retention of ultrafine particles in the human lung
Source: Eur Respir J 2004; 24: Suppl. 48, 236s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept